145 related articles for article (PubMed ID: 31084400)
41. Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.
Cai H; Lin L; Cai H; Tang M; Wang Z
Med Oncol; 2013 Jun; 30(2):499. PubMed ID: 23430441
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNA PWRN1 is lowly expressed in osteosarcoma and modulates cancer proliferation and migration by targeting hsa-miR-214-5p.
Shi J; Fu Q; Yang P; Yi Z; Liu S; Wang K
IUBMB Life; 2020 Nov; 72(11):2444-2453. PubMed ID: 32870579
[TBL] [Abstract][Full Text] [Related]
43. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
44. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
Yao Q; Pei Y; Zhang X; Xie B
Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
[TBL] [Abstract][Full Text] [Related]
45. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
Lian D; Wang ZZ; Liu NS
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5.
Jiang W; Zheng J; Yu T; Wang J
Oncol Rep; 2017 Aug; 38(2):1099-1107. PubMed ID: 28627703
[TBL] [Abstract][Full Text] [Related]
48. miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.
Wang L; Shi G; Zhu D; Jin Y; Yang X
Cancer Biother Radiopharm; 2019 Aug; 34(6):405-412. PubMed ID: 31411930
[No Abstract] [Full Text] [Related]
49. Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma.
Fei D; Zhang X; Liu J; Tan L; Xing J; Zhao D; Zhang Y
Cell Physiol Biochem; 2018; 51(3):1364-1375. PubMed ID: 30481787
[TBL] [Abstract][Full Text] [Related]
50. miR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor.
Lv T; Liu Y; Li Z; Huang R; Zhang Z; Li J
Cancer Biomark; 2018; 23(3):315-322. PubMed ID: 30223385
[TBL] [Abstract][Full Text] [Related]
51. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
[No Abstract] [Full Text] [Related]
52. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
[TBL] [Abstract][Full Text] [Related]
53. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
[TBL] [Abstract][Full Text] [Related]
54. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
Dai J; Lu L; Kang L; Zhang J
Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
[TBL] [Abstract][Full Text] [Related]
55. MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
Cheng DD; Yu T; Hu T; Yao M; Fan CY; Yang QC
Oncotarget; 2015 Dec; 6(40):42761-72. PubMed ID: 26498360
[TBL] [Abstract][Full Text] [Related]
56. Roles of microRNA-206 in osteosarcoma pathogenesis and progression.
Bao YP; Yi Y; Peng LL; Fang J; Liu KB; Li WZ; Luo HS
Asian Pac J Cancer Prev; 2013; 14(6):3751-5. PubMed ID: 23886177
[TBL] [Abstract][Full Text] [Related]
57. MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma.
Gong N; Gong M
Medicine (Baltimore); 2018 Jul; 97(29):e11100. PubMed ID: 30024497
[TBL] [Abstract][Full Text] [Related]
58. A Clinical Evaluation of Circulating MiR-106a and Raf-1 as Breast Cancer Diagnostic and Prognostic Markers.
Ahmed Mohmmed E; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3513-3520. PubMed ID: 34837907
[TBL] [Abstract][Full Text] [Related]
59. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
[TBL] [Abstract][Full Text] [Related]
60. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
